Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if COAG is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
19 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 3
56 filers reported a long position in COAG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $286.8M | 7.8M | New |
| Novo Holdings A/S | $153.6M | 4.2M | New |
| FMR LLC | $135.8M | 3.7M | New |
| Capital International Investors | $132.4M | 3.6M | New |
| Deep Track Capital, LP | $132.3M | 3.6M | New |
| Siren, L.L.C. | $76.6M | 2.1M | New |
| Avoro Capital Advisors LLC | $70.7M | 1.9M | New |
| Bain Capital Life Sciences Investors, LLC | $60.6M | 1.7M | New |
| JPMORGAN CHASE & CO | $42.3M | 1.2M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.7M | 780.8K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.